Why This Tesla Deal Is Huge for Piedmont Lithium

Photo of Chris Lange
By Chris Lange Published
Why This Tesla Deal Is Huge for Piedmont Lithium

© Jag_cz / iStock Editorial via Getty Images

Piedmont Lithium Ltd. (NASDAQ: PLL) has announced a binding agreement with Tesla Inc. (NASDAQ: TSLA | TSLA Price Prediction) to supply spodumene (SC6) concentrate from Piedmont’s North Carolina deposit. Shares of Piedmont nearly tripled on the news.

This deal is for an initial five-year term on a fixed-price binding purchase commitment from the delivery of first product, and it may be extended by mutual agreement for a second five-year term. The agreement covers a fixed commitment representing about one-third of Piedmont’s planned SC6 production of 160,000 tonnes per annum for the initial five-year term, as well as an additional quantity to be delivered at Tesla’s option.

The SC6 sales are expected to generate between 10% and 20% of Piedmont’s total revenues from its proposed integrated mine-to-hydroxide project for the initial five-year term. The agreement is conditioned on Tesla and Piedmont agreeing to a start date for spodumene concentrate deliveries between July 2022 and July 2023, based on the development schedules of both parties.

Management was quick to note that the agreement highlights the strategic importance of Piedmont’s unique American spodumene deposit and confirms the trend toward spodumene as the preferred feedstock for the lithium hydroxide required in high-nickel batteries.

[nativounit]

Also, Piedmont will simultaneously advance its plans to produce lithium hydroxide in North Carolina, using a combination of internally produced spodumene concentrate, as well as material sourced from other producers around the world.

Piedmont Lithium stock traded up about 178% on Monday, at $30.60 in a 52-week range of $4.00 to $43.99. The consensus price target is $20.00.

Tesla stock was up about 3% to $418.23, with a 52-week range of $44.86 to $502.49. The consensus price target is $314.68.

[recirclink id=769589][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MOS Vol: 14,295,760
STX Vol: 3,198,282
ALB Vol: 3,265,097
INTC Vol: 151,379,140
WDC Vol: 6,291,434

Top Losing Stocks

CTRA Vol: 73,319,495
ADBE Vol: 25,063,608
LEN Vol: 6,260,516
TKO Vol: 1,889,802
SMCI Vol: 85,032,138